Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
GE Healthcare, Shanghai, 201203, People's Republic of China.
Eur Radiol. 2022 Oct;32(10):6953-6964. doi: 10.1007/s00330-022-08830-3. Epub 2022 Apr 29.
This study aimed to explore and validate the value of different radiomics models for differentiating benign and malignant parotid tumors preoperatively.
This study enrolled 388 patients with pathologically confirmed parotid tumors (training cohort: n = 272; test cohort: n = 116). Radiomics features were extracted from CT images of the non-enhanced, arterial, and venous phases. After dimensionality reduction and selection, radiomics models were constructed by logistic regression (LR), support vector machine (SVM), and random forest (RF). The best radiomic model was selected by using ROC curve analysis. Univariate and multivariable logistic regression was applied to analyze clinical-radiological characteristics and identify variables for developing a clinical model. A combined model was constructed by incorporating radiomics and clinical features. Model performances were assessed by ROC curve analysis, and decision curve analysis (DCA) was used to estimate the models' clinical values.
In total, 2874 radiomic features were extracted from CT images. Ten radiomics features were deemed valuable by dimensionality reduction and selection. Among radiomics models, the SVM model showed greater predictive efficiency and robustness, with AUCs of 0.844 in the training cohort; and 0.840 in the test cohort. Ultimate clinical features constructed a clinical model. The discriminatory capability of the combined model was the best (AUC, training cohort: 0.904; test cohort: 0.854). Combined model DCA revealed optimal clinical efficacy.
The combined model incorporating radiomics and clinical features exhibited excellent ability to distinguish benign and malignant parotid tumors, which may provide a noninvasive and efficient method for clinical decision making.
The current study is the first to compare the value of different radiomics models (LR, SVM, and RF) for preoperative differentiation of benign and malignant parotid tumors. A CT-based combined model, integrating clinical-radiological and radiomics features, is conducive to distinguishing benign and malignant parotid tumors, thereby improving diagnostic performance and aiding treatment.
本研究旨在探索和验证不同放射组学模型在术前鉴别腮腺良恶性肿瘤中的价值。
本研究纳入了 388 例经病理证实的腮腺肿瘤患者(训练队列:n=272;测试队列:n=116)。从平扫、动脉期和静脉期 CT 图像中提取放射组学特征。经过降维和选择后,使用逻辑回归(LR)、支持向量机(SVM)和随机森林(RF)构建放射组学模型。通过 ROC 曲线分析选择最佳放射组学模型。应用单变量和多变量逻辑回归分析临床-影像学特征,并确定用于开发临床模型的变量。通过纳入放射组学和临床特征构建联合模型。通过 ROC 曲线分析评估模型性能,通过决策曲线分析(DCA)评估模型的临床价值。
共从 CT 图像中提取了 2874 个放射组学特征。经过降维和选择,有 10 个放射组学特征具有价值。在放射组学模型中,SVM 模型显示出更高的预测效率和稳健性,在训练队列中的 AUC 为 0.844;在测试队列中的 AUC 为 0.840。最终的临床特征构建了临床模型。联合模型的判别能力最佳(AUC,训练队列:0.904;测试队列:0.854)。联合模型 DCA 显示出最佳的临床效果。
纳入放射组学和临床特征的联合模型在鉴别腮腺良恶性肿瘤方面表现出优异的能力,可能为临床决策提供一种无创、高效的方法。
本研究首次比较了不同放射组学模型(LR、SVM 和 RF)在术前鉴别腮腺良恶性肿瘤中的价值。基于 CT 的联合模型,整合了临床-影像学和放射组学特征,有助于鉴别腮腺良恶性肿瘤,从而提高诊断性能并辅助治疗。